Abstract:Introduction: Corrected QT interval (QTc) prolongation is the known side effect of multiple medications especially in antipsychotic and antiarrhythmic family. Patients with either inherited or secondary prolonged QTc should be monitored closely as they can develop life threatening complications like Torsades de-pointes and ventricular fibrillation. Here we present a case of cardiac arrest secondary to dexmedetomidine. Case: A 49-year-old female with history of bipolar disorder was admitted to intensive unit for seizure after intentional ingestion of uncounted amount of diphenhydramine pills. Patient was intubated for airway protection and started on propofol. Her vitals at the time of admission included the pulse rate of 76, blood pressure of 102/49 mmHg. Her urine drug screen was positive for TCA and cannabinoids. Her ECG at the time of admission was significant for prolonged QTC of 600msec that improved to 460msec in the consecutive ECGs after administration of total of 4mg intravenous magnesium. Continuous EEG was negative for seizure and she was weaned off sedation. After awakening, she became agitated, after pushes of benzodiazepines, was eventually started on dexmedetomidine. Twenty minutes after starting low dose dexmedetomidine, patient was noted to be in cardiac arrest. Reviewing telemetry prior to event, revealed the R on T phenomenon and Torsades de pointes that lasted for few seconds with progression into ventricular fibrillation. Discussion: Currently dexmedetomidine is labeled with a low to possible risk of Torsade de pointes and QTC prolongation. Dexmedetomidine induced Torsade de pointes might be explained by bradycardia in patients which causes further prolongation of QT interval. Studies have shown that continuous IV infusion of dexmedetomidine at rate of 0.3 mcg/kg/hour can worsen QTC prolongation. Conclusions: In this case we present a case of VFib arrest secondary to Torsade after twenty minutes of infusion of dexmedetomidine without any sign of bradycardia prior to the event. This carries a significant importance as it shows this drug carries a potential risk of QTc prolongation similar to previous studies. Whether this side effect is dose dependent or not requires further investigation.

Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning

Convulsive Syncope Related to a Small Dose of Quetiapine in an Adolescent with Bipolar Disorder

Torsade de pointes in a patient with complete atrioventricular block and pacemaker failure, misdiagnosed with epilepsy.

Torsade de pointes and sudden death associated with diabetic autonomic diarrhoea--a case report

Prevention of Torsade de Pointes in Hospital Settings

Torsade de pointes caused by citalopram during the pacemaker battery-depletion phase: A case report

Abstract 18979: Calm Before the Storm: Exploring the Risk of Torsades De Pointes With Dexmedetomidine Administration

Incidences, risk factors, and clinical correlates of severe QT prolongation after the use of quetiapine or haloperidol

Evolving trends of pharmaceutical poisonings associated with QRS complex prolongation

Torsades de Pointe Associated with Trazodone Consumption

Treatment of status epilepticus and prolonged QT after massive intentional bupropion overdose with lidocaine

QT Prolongation Preceding Ventricular Fibrillation After Amiodarone Administration: A Case Report

Diagnosis and Treatment of Drug Induced Acquired Long QT Syndrome

Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia

Dobutamine Infusion for Unmasking Long QT Syndrome and Torsades De Pointes.

The Perfect Storm: Abnormal Baseline QT With Chronic Methadone Use and Serious Hypokalemia

Vicious LQT induced by a combination of factors different from hERG inhibition

Risk of fatal arrhythmic events in long QT syndrome patients after syncope.

Hydroxyzine-Induced Torsade De Pointes: A Case Report and a Literature Review

An Updated Safety Review of the Relationship Between Atypical Antipsychotic Drugs, the QTc Interval and Torsades de Pointe As: Implications for Clinical Use

Torsades de Pointes with QT prolongation related to donepezil use